Llwytho...

Valbenazine and Deutetrabenazine for Tardive Dyskinesia

Tardive dyskinesia (TD) is a medication-induced permanent movement disorder with no United States Food and Drug Administration (FDA)-approved treatments prior to 2017. Although TD is medication-induced, patients who have responded well to antipsychotics might not be candidates for dose reduction or...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Innov Clin Neurosci
Prif Awduron: Touma, Katie T. B., Scarff, Jonathan R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Matrix Medical Communications 2018
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6040721/
https://ncbi.nlm.nih.gov/pubmed/30013814
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!